Show simple item record

dc.contributor.authorNyindo, M
dc.contributor.authorBorus, P K
dc.contributor.authorFarah, I O
dc.contributor.authorOguya, F O
dc.contributor.authorMakawiti, D W
dc.date.accessioned2013-06-10T07:27:14Z
dc.date.available2013-06-10T07:27:14Z
dc.date.issued1995
dc.identifier.citationSchistosoma mansoni in the baboon: modulation of pathology after vaccination with polyclonal anti-idiotypic antibodies. Nyindo M, Borus PK, Farah IO, Oguya FO, Makawiti DW. Scand J Immunol. 1995 Dec;42(6):637-43.en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/8552987
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/30428
dc.description.abstractVaccination of five baboons with an anti-idiotypic vaccine to irradiated Schistosoma mansoni cercariae resulted in nearly 19% protection compared to 39% protection conferred to five baboons vaccinated with an irradiated vaccine. Vaccination with the anti-idiotypic antibodies resulted in a significant reduction of pathology and granuloma size following challenge with live unattenuated cercariae. Results presented in this work are considered highly significant because the anti-idiotypic vaccine markedly influenced schistosomiasis morbidity which is the main consideration in this disease.en
dc.language.isoenen
dc.titleSchistosoma mansoni in the baboon: modulation of pathology after vaccination with polyclonal anti-idiotypic antibodies.en
dc.typeArticleen
local.publisherParasitology, National Museums of Kenya, Nairobi, Kenya.en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record